The Testosterone Tell A companion to the investigation "The Same Exam." The reporting establishes the record; this is what I think it means.
Pete Hegseth wants you to believe he is building a harder military. This week he announced that troops over 30 will be screened for low testosterone and offered the hormone to top them up, and he wrapped it in the vocabulary of the warrior — lethality, readiness, the "biological foundation required to sustain the fight." He posted it under a banner reading "The High-T Department of War."
There is no Department of War. Congress never renamed anything; the legal title is still the Department of Defense, and it stays that way until a statute says otherwise. What exists is a secondary title, authorized by executive order, and a Secretary who ordered the nameplates changed to match. That gap — between the title he awarded himself and the one the law actually assigns him — is worth holding onto, because the testosterone policy runs on the
same gap between the performance and the substance.
Start with the substance, because it collapses on contact. Testosterone falls with age; that is biology, not pathology. The Mayo Clinic calls the roughly 1- percent-a-year decline after 30 a normal part of aging. A real deficiency takes symptoms plus two low morning blood draws to diagnose — and even now, the American Urological Association estimates up to a third of men already on the hormone never cleared that bar. The FDA won't approve it for men who simply don't have a medical problem. So a policy that screens an entire healthy population against a "low" line is not medicine finding the sick. It is a funnel, and what comes out the bottom is a lot of men medicating a number their own bodies produced on schedule — at the cost of their fertility, their natural hormone production, and a thicker path toward a stroke.
That is the giveaway on its own. The record around it removes all doubt.
The same department now selling testosterone as strength has spent eighteen months removing strength from the building. Close to three dozen senior officers fired or sidelined. Nearly 60 percent of them women or Black, by the count of the Senate Armed Services Committee's ranking Democrat — in a corps where those groups are under 20 percent of the whole. The first woman to lead the Navy, gone and smeared as a "DEI hire." The first woman to run the Naval Academy, gone. The military's representative to NATO, gone. And when a Black female combat engineer came up for a star, an aide reportedly relayed that the President wouldn't want her standing next to him in the photos. There are now zero women in the military's top jobs. The department calls this merit. Merit does not produce a clean sweep. Then the part that should end the conversation. This administration discharged transgender troops by the thousand — including transgender men, who take testosterone, and who get measurably stronger on it. The exact effect Hegseth is now marketing to everyone else. They were shown the door with a discharge code that can brand them a security risk for life, careers past the twenty-year mark torn up.
And note what the department called that hormone when they were the ones taking it — an unnecessary expense. The Advocate reported that contradiction this week; I'm not the first to it. The identical treatment, on the identical drug, is a waste of taxpayer money in a transgender soldier and a strategic investment in everyone else. Same pharmacy. Different verdict. The only variable is the body it goes into.
Then there's the part that turned my stomach when I found it. In May 2025, a senior defense official told reporters the services would use commanders and annual medical screenings to find transgender troops who hadn't come forward. The annual physical — the periodic health assessment. That is the exact same exam Hegseth just announced he's using to screen everyone for testosterone. One year it's a dragnet. The next year it's a gift. Same appointment, same clipboard, and what happens to you there depends entirely on which category the department has filed you under.
So line them up. Testosterone in the ordinary male soldier: an asset to be optimized. Testosterone in the transgender soldier: grounds for removal. And the decorated woman? No hormone required — she was simply never the picture.
The standard isn't performance — it's who you are. And the testosterone policy makes it visible, by treating the exact same molecule as an asset in one body and a disqualifier in another.
Hegseth keeps saying he wants one force, judged on ability alone. Take him at his word and grade him by it. A department serious about ability does not bench its most combat-tested women, does not expel men who are getting stronger, and does not turn ordinary aging into a diagnosis for everyone left over. It does not need a hormone program to prove its troops are men. What Hegseth built is a force sorted by identity and handed testosterone as a cover story — the same maneuver as the sign on his door, which says "War" because the law that says "Defense" was never going to let him win by decree.
The molecule doesn't lie. It is identical in all of them. Only the verdict changes — and the verdict was never about strength.
If you haven’t read the investigative Piece “Same Test”, please head over to investigtation and read it, then come back and I promise this will make more sense.